Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.

被引：3
|
作者：
Roschewski, Mark J.
Melani, Christopher Joseph
Pittaluga, Stefania
Dunleavy, Kieron
Saba, Nakhle S.
Grant, Cliona
Aaron, Joan
Jacob, Allison
Yusko, Erik
Steinberg, Seth M.
Jaffe, Elaine S.
Wiestner, Adrian
Wilson, Wyndham Hopkins
机构：
[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[3] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[4] Tulane Univ Hlth Sci Ctr, New Orleans, LA USA
[5] St James Hosp, Dublin, Ireland
[6] NCI, Bethesda, MD 20892 USA
[7] Adapt Biotechnol, Seattle, WA USA
[8] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.7576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7576
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma
    Lakhotia, Rahul
    Melani, Christopher
    Pittaluga, Stefania
    Dunleavy, Kieron
    Saba, Nakhle S.
    Lucas, A. Nicole
    Jacob, Allison
    Yusko, Erik
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wiestner, Adrian
    Wilson, Wyndham H.
    Roschewski, Mark
    BLOOD, 2018, 132
  • [2] Circulating tumor DNA of classical Hodgkin lymphoma.
    Pirosa, Maria Cristina
    Bruscaggin, Alessio
    Di Bergamo, Lodovico Terzi
    Salehi, Matin
    Spina, Variera
    Pini, Katia
    Bocchetta, Simone
    Giordano, Claudia
    Forestieri, Gabriela
    Bergesio, Fabrizio
    Gattei, Valter
    Zaucha, Jan Maciej
    Hohaus, Stefan
    Santoro, Armando
    Carlo-Stella, Carmelo
    Gaidano, Gianluca
    Cavalli, Franco
    Zucca, Emanuele
    Ceriani, Luca
    Rossi, Davide
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
    Lakhotia, Rahul
    Melani, Christopher
    Dunleavy, Kieron
    Pittaluga, Stefania
    Saba, Nakhle
    Lindenberg, Liza
    Mena, Esther
    Bergvall, Ethan
    Lucas, Andrea Nicole
    Jacob, Allison
    Yusko, Erik
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wiestner, Adrian
    Wilson, Wyndham H.
    Roschewski, Mark
    BLOOD ADVANCES, 2022, 6 (08) : 2667 - 2680
  • [4] Mantle cell lymphoma.
    Densmore J.J.
    Williams M.E.
    Current Treatment Options in Oncology, 2000, 1 (3) : 281 - 285
  • [5] DNA repair abnormalities leading to radiation sensitivity in mantle cell lymphoma.
    Mkacher, R
    Farace, F
    Ribrag, V
    Dossou, J
    Bernheim, A
    Parmentier, C
    Turhan, AG
    BLOOD, 2000, 96 (11) : 333A - 333A
  • [6] The changing face of mantle cell lymphoma.
    Goepel, JR
    Lorigan, PC
    Vandenberghe, EA
    Allen, JE
    Hammond, DW
    Hancock, BW
    BRITISH JOURNAL OF CANCER, 1998, 78 : 5 - 5
  • [7] Identification of candidate tumor suppressor genes silenced epigenetically in mantle cell lymphoma.
    Kawamata, N
    Saitoh, T
    Sahajiri, S
    Koeffler, PH
    BLOOD, 2005, 106 (11) : 841A - 841A
  • [8] In vitro and in vivo models for mantle cell lymphoma.
    Ford, RJ
    Luthra, R
    Bryant, J
    Tamayo, A
    Curiel, T
    BLOOD, 1998, 92 (10) : 314A - 314A
  • [9] Flavopiridol monotherapy is inactive in mantle cell lymphoma.
    Smith, SM
    Liebowitz, D
    van Besien, K
    Fishkin, P
    Grinblatt, D
    Vokes, EE
    BLOOD, 2003, 102 (11) : 306B - 306B
  • [10] Association of Helicobacter pylori with mantle cell lymphoma.
    Paglieroni, TG
    Schoenman, L
    Simon, GE
    Kuramoto, IK
    MacKenzie, MR
    Kailath, JM
    Wong-Lee, J
    BLOOD, 2000, 96 (11) : 244B - 244B
12345